GlassScriptPhysician profile
Jenna D Freitag
NPI 1992045686
$4,226.45
in general payments reported to CMS, 2019-2025
42 companies · $492 in 2025
The $492 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,164 · 2022: $705 · 2023: $297 · 2024: $569 · 2025: $492.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,357.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $791.94 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $350.28 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $283.85 | 2021-2025 | Farxiga |
| Lilly USA, LLC | $274.93 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Exact Sciences Corporation | $215.52 | 2023-2024 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $213.45 | 2021-2025 | |
| Glaxosmithkline, LLC. | $198.30 | 2021-2022 | |
| Abbott Laboratories | $169.47 | 2021-2024 | Freestyle Libre 3 |
| Pfizer INC. | $165.69 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $152.86 | 2021-2022 | |
| Baxter Healthcare | $119.24 | 2025 | Coseal, Preveleak |
| Janssen Pharmaceuticals, INC | $115.46 | 2021-2022 | |
| Almatica Pharma LLC | $91.52 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $87.52 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $81.83 | 2021-2022 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Freitag listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.